$GILD Headlines Wynn, Newmont lead gainers; Macy’s,

New Post Public Reply Private Reply Replies (0) Message Board

Jan 12, 2015 at 9:44 AM

$GILD Headlines

Wynn, Newmont lead gainers; Macy’s, Bed Bath & Beyond slump 11:05 a.m. Jan. 9, 2015 - Sue Chang
Fifteen stocks for 2015, part 1 10:36 a.m. Jan. 9, 2015 - The Trading Deck
AbbVie predicts sharp increase in earnings 4:56 p.m. Jan. 8, 2015 - MarketWatch.com
Gilead Sciences shares rise 2.4% 9:32 a.m. Jan. 6, 2015 - Sue Chang
Gilead to buy liver disease treatment from Germany's Phenex 8:39 a.m. Jan. 6, 2015 - Ciara Linnane
Gilead, CVS strike deal on Hepatitis C drugs 1:47 p.m. Jan. 5, 2015 - Russ Britt
Eight charts plot the year in finance 12:45 p.m. Dec. 30, 2014 - Ophir Gottlieb
Are consumers getting gouged on health care? 9:35 a.m. Dec. 30, 2014 - Russ Britt
S&P 500 rises to record, but Dow snaps 7-day win streak 4:24 p.m. Dec. 29, 2014 - Sara Sjolin
Manitowoc, Gilead climb; Tesla slips 11:12 a.m. Dec. 29, 2014 - Wallace Witkowski
Mon., Dec. 29, 2014: Watch Manitowoc Stock 10:32 a.m. Dec. 29, 2014 - MarketWatch
Gilead shares up 3% as Morgan Stanley upgrades to overweight 10:07 a.m. Dec. 29, 2014 - Ciara Linnane
Gilead shares up 2.9% in early trade 9:52 a.m. Dec. 29, 2014 - Ciara Linnane
Gilead upgraded to overweight from equal-weight at Morgan Stanley 9:52 a.m. Dec. 29, 2014 - Ciara Linnane
U.S. Stock Futures Fall, Following Europe's Lead 9:51 a.m. Dec. 29, 2014 - MarketWatch
Gilead Sciences, energy plays lead S&P advancers 9:34 a.m. Dec. 29, 2014 - Silvia Ascarelli
Why speculators see opportunity in younger, cyclical stocks 2:50 p.m. Dec. 26, 2014 - The Trading Deck
GoPro, Gilead Sciences, Celgene gain 11:27 a.m. Dec. 26, 2014 - MarketWatch
GoPro, Adamas climb, Cal-Maine slides 10:06 a.m. Dec. 24, 2014 - MarketWatch
Gilead's stock, up 2%, is early volume leader on Nasdaq 9:37 a.m. Dec. 24, 2014 - Tomi Kilgore

My Predictions For 2015 - Final Chapter 37 min ago - Seeking Alpha
Merck Accelerates Drug-Submission Plans 11:04 p.m. Jan. 11, 2015 - The Wall Street Journal Interactive Edition
We're Drowning In Crude Oil 2:59 a.m. Jan. 11, 2015 - Seeking Alpha
Weekly CEO Sells Highlight: Six Flags Entertainment Corp, Gilead Sciences Inc, Ingersoll-Rand ... 11:45 p.m. Jan. 10, 2015 - GuruFocus.com
Beware Of Premature Market Contractions 5:38 a.m. Jan. 10, 2015 - Seeking Alpha
Gilead CEO’s Latest Sale Totals $14.3M 5:55 p.m. Jan. 9, 2015 - Barrons.com
Crude Awakening As Energy Squeezes Overall Q4 Profit 4:58 p.m. Jan. 9, 2015 - Investors Business Daily
Seeking Alpha's Biotech Weekly: Gilead Rises With Phenex, Bass's Patent Attack, And More 4:00 p.m. Jan. 9, 2015 - Seeking Alpha
The Hepatitis C Price War Begins: Gilead Plays To Win By Signing With CVS 2:44 p.m. Jan. 9, 2015 - Seeking Alpha
Regeneron Can Generate 25% Upside for Investors 1:58 p.m. Jan. 9, 2015 - Barrons.com
AbbVie Stock Down After Guidance, Downgrade 10:49 a.m. Jan. 9, 2015 - Investors Business Daily
Gilled Buying Vertex Among Bold Biotech Stock Predictions for 2015 10:42 a.m. Jan. 9, 2015 - TheStreet.com
Gilead Continues to Recover from Express Scripts Loss 10:04 a.m. Jan. 9, 2015 - 247WallSt.com
Gilead: Focusing On The Expansion Of Its Liver Drug Portfolio 9:26 a.m. Jan. 9, 2015 - Seeking Alpha
Trade-Ideas: Gilead (GILD) Is Today's Post-Market Leader Stock 5:37 p.m. Jan. 8, 2015 - TheStreet.com
AbbVie Predicts Big Profit Increase 4:52 p.m. Jan. 8, 2015 - The Wall Street Journal Interactive Edition
Hep C Drug Deal Raises Patient-Choice Concerns 3:51 p.m. Jan. 8, 2015 - The Wall Street Journal Interactive Edition
Five Stock Picks for 2015 3:00 p.m. Jan. 8, 2015 - FOXBusiness
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1 1:09 p.m. Jan. 8, 2015 - TheStreet.com
The 2015 Calendar Of NASH Trial Catalysts: Gilead Adds To Its NASH Arsenal 8:19 a.m. Jan. 8, 2015 - Seeking Alpha

Reveal Earnings Forecast for Arena Pharmaceuticals, Petrobras, Alibaba, Apple, Gilead Sciences, and Applied Materials 8:45 a.m. Jan. 9, 2015 - PR Newswire - PRF
Earnings Forecast for Apple, Alibaba, Twitter, Gilead Sciences, Michael Kors, and Tesla 8:45 a.m. Jan. 7, 2015 - PR Newswire - PRF
Biotechs to Follow in 2015 off Fresh Insider Moves 10:00 a.m. Jan. 6, 2015 - ACCESSWIRE
Gilead Sciences Announces Acquisition of Phenex Pharmaceuticals’ Development Program for Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases 8:31 a.m. Jan. 6, 2015 - BusinessWire - BZX
Factors Moving Markets: Complementary Reports on United Parcel Service, Gilead, Manitowoc, EMC Corporation, and LiveDeal 9:10 a.m. Dec. 30, 2014 - PR Newswire - PRF
Biotech Stocks Technical Data -- Gilead Sciences, ImmunoGen, Exelixis, Cubist Pharma, and Vanda Pharma 8:55 a.m. Dec. 30, 2014 - PR Newswire - PRF
Gilead Announces Amended Agreements With Janssen to Develop and Commercialize Tenofovir Alafenamide-Based Single Tablet Regimens for HIV Treatment 8:30 a.m. Dec. 29, 2014 - BusinessWire - BZX
Critical Alerts For Achillion Pharmaceuticals, AT&T, Peabody Energy, Gilead Sciences and Facebook Released By InvestorsObserver 9:31 a.m. Dec. 23, 2014 - PR Newswire - PRF
AHF Lauds Express Scripts for Dropping Gilead’s Sovaldi in Favor of Cheaper Hepatitis C Treatment 9:01 a.m. Dec. 23, 2014 - BusinessWire - BZX
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
Reveal Earnings Forecast for Apple, Halliburton, American Realty Capital Properties, Gilead Sciences, Zynga, and Bank of America 8:45 a.m. Dec. 16, 2014 - PR Newswire - PRF
Philippe C. Bishop, MD, to Join Gilead as Senior Vice President, Hematology and Oncology Therapeutics 8:30 a.m. Dec. 15, 2014 - BusinessWire - BZX
Critical Alerts For Abercrombie & Fitch, Whole Foods Market, Gilead Sciences, JC Penney and Activision Blizzard Released By InvestorsObserver 9:31 a.m. Dec. 10, 2014 - PR Newswire - PRF
Class Action Lawsuit Challenges the Exorbitant Pricing of Gilead's Hepatitis-C Drug Sovaldi 6:39 p.m. Dec. 9, 2014 - PR Newswire - PRF
BetterInvesting Magazine Releases February Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use 4:43 p.m. Dec. 9, 2014 - PR Newswire - PRF
Biogen Idec and Gilead Sciences Join the National Pharmaceutical Council 9:15 a.m. Dec. 9, 2014 - PR Newswire - PRF
Gilead Presents Follow-up Data from Zydelig Registrational Studies in Patients with Chronic Lymphocytic Leukemia, Follicular Lymphoma and Small Lymphocytic Lymphoma 10:00 a.m. Dec. 8, 2014 - BusinessWire - BZX
Reveal Earnings Forecast for Gilead Sciences, Apple, Transocean, Halliburton, Ctrip, and Sirius XM 8:45 a.m. Dec. 8, 2014 - PR Newswire - PRF
Reveal Earnings Forecast for Gilead Sciences, Kinder Morgan, JD.Com, Sirius XM, Apple, and Plug Power 8:45 a.m. Dec. 4, 2014 - PR Newswire - PRF
Earnings Forecast Reports for Apple, Alibaba, Kinder Morgan, Gilead Sciences, Plug Power, and Yahoo 8:45 a.m. Dec. 2, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Medical Device Manufacturing: $135B Market by 2031

Skyrocketing Demand in Medical Device Manufacturing You're looking at a market that's gearing up to hit a whopping $135.47 billion by 2031. That's a big leap from its $85.59 billion stature in 2026, showing a strong 9.6% compound annual growth rate (CAGR). Now, if that doesn't get your investor rollercoaster senses tingling, I don't know what will. Key Growth Drivers The...

LabWare Loop: A Game Changer for Lab Data Integrity

Breaking Down Silos in Lab Environments When it comes to the controlled chaos of laboratory operations, data integrity is the name of the game. We're talking about a new way of doing things that doesn't demand a physics degree just to connect the dots between gizmos and databases. Enter LabWare Loop, a solution that's rewriting the data playbook by linking multi-vendor...

DERMALOG Bolsters Biometric Defense with Key Wins

DERMALOG Rides High with PAD Success Germany-based DERMALOG just gave biometric crooks a run for their money. In a testament to gutsy tech work, they've hit a homerun with the latest independent security evaluations. They’ve managed to spot and shut down all 1,500 tried and tested spoofs in presentation attacks—think photos, videos, and phony fingerprints. That’s no...

Vertiv's Explosive Q3 Growth: A 2026 Power Move

Vertiv's Third Quarter Triumph Imagine a company blowing past expectations like a hot knife through butter—yeah, that's Vertiv for you in 2026. These guys didn’t just ride the wave; they created a tsunami in the digital infrastructure sector. Net sales ballooned by a staggering 61% compared to last year's same quarter, pulling in $4.313 billion. When you consider the...

Seatrium & Karpowership Boost Southeast Asia's Energy Future

Anchoring Ambitions: A Fresh Power Pact Seatrium Limited and Karpowership are rolling up their sleeves for a tough yet lucrative mission in Southeast Asia. These two powerhouses are pooling their expertise to beef up the region’s energy supply through floating power solutions and digital infrastructure. You gotta give it to them—they’re not skimping on the ambition....

North Fork Mono Casino Opens: A $750 Million Bet

A New Spin in Madera Cue the fanfare, folks! The North Fork Mono Casino just threw open its doors earlier than expected today, marking a hefty $750 million wager right in the heart of California's Central Valley. It's a big deal managed by Station Casinos, part of Red Rock Resorts, Inc. (NASDAQ: RRR)—teaming up with the North Fork Rancheria of Mono Indians for a...

US State Dept. & IICA: Strengthening Disaster Response

Bridging Borders to Tackle Disasters It seems like everyone and their grandma talks disaster aid, but when two giants like the US State Department's Bureau of Disaster and Humanitarian Response (DHR) and the Inter-American Institute for Cooperation on Agriculture (IICA) grab a coffee—real serious action is brewing. Why This Matters The partnership's not just talk. Let's...

Total Play's Q3 2026: Subscriber Surge, Debt Down

Subscriber Growth Amidst Financial Hurdles Here’s the deal with Total Play's third-quarter results for 2026: they’ve got a mixed bag of numbers that’ll make any investor think twice. The headline is a hefty rise in subscribers—a net gain of 143,340 in the Residential segment thanks to their top-tier internet services. But don’t start cheering just...

Archera Raises $15M to Redefine Cloud Commitment Models

Rethinking Cloud and AI Contracts A new day in cloud economics has dawned, folks, and it’s shining over Archera, a name you'll want to remember if you're navigating the murky waters of cloud and AI spending. As the world dashes headlong into AI, cloud investments are becoming a game of either overcommitting or missing out on key discounts. Archera's snagged a $15...

Covalent's Bet on AML Analytics: A Defense Revolution

The Big Play: AI Meets Financial Defense You know when a private equity firm swoops in, it's like the cavalry arriving. Covalent Equity Partners just did that for AML Analytics, or AMLA for short. A payday for them, sure, but it's more about amplifying AMLA's already hefty punch against financial crime, using AI to boot. Now, if AI's mentioned, you know someone's getting...